Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.
Clinical trial NCT01989143 · COMPLETED
Trial details
- NCT number
- NCT01989143
- Sponsor
- Telavant, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-03-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.